mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.0017 |
1 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0016 |
1 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0013 |
1 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0012 |
1 |
mRNA |
skepinone-L |
CTRPv2 |
pan-cancer |
AAC |
0.0019 |
1 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0011 |
1 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.0015 |
1 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00086 |
1 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.00089 |
1 |